Practice
Featured experience
Rare dismissal of criminal antitrust charge against chicken supply executive
We secured the dismissal of price-fixing and bid-rigging charges brought by the DOJ Antitrust Division against Jason McGuire
Declinations for communications technology company involving self-enrichment scheme
We secured declinations from the SEC and DOJ following our client’s internal investigation
Fintech lender in connection with Paycheck Protection Program investigations
We are representing the client in regulatory and congressional inquiries
PENTAX Medical deferred prosecution agreement from DOJ
Davis Polk represented PENTAX Medical, a global medical device manufacturer that is a division of HOYA Group, in a criminal…
SEC termination letter for multinational company
Our client faced no charges at the termination of a case involving sanctions, books and records, and internal controls
LATAM Airlines Group emerges from chapter 11 bankruptcy
We advised Delta in connection with LATAM’s chapter 11
Rare dismissal of criminal antitrust charge against chicken supply executive
We secured the dismissal of price-fixing and bid-rigging charges brought by the DOJ Antitrust Division against Jason McGuire
FCPA declination for an engineering company involving corruption allegations
We secured a DOJ FCPA declination while the European company negotiated a resolution with its home country’s authorities
Declinations for communications technology company involving self-enrichment scheme
We secured declinations from the SEC and DOJ following our client’s internal investigation
Multiple companies in SEC investigation of the SolarWinds cyber breach
We are advising multiple public companies in the SEC investigation of the compromise of SolarWinds software
Fintech lender in connection with Paycheck Protection Program investigations
We are representing the client in regulatory and congressional inquiries
SEC declination for ICICI Bank
Davis Polk represented ICICI Bank Limited (“ICICI” or the “Bank”) in connection with an investigation by the U.S. Securities…
Complete victory for AstraZeneca in Anti-Terrorism Act case
On July 17, 2020, Davis Polk secured a complete dismissal on behalf of its client, AstraZeneca, in an Anti-Terrorism Act (…
PENTAX Medical deferred prosecution agreement from DOJ
Davis Polk represented PENTAX Medical, a global medical device manufacturer that is a division of HOYA Group, in a criminal…